Amneal Pharmaceuticals, Inc. (AMRX) › Gross ProfitAmneal Pharmaceuticals, Inc. (AMRX) — Gross ProfitAnnual figures by fiscal year, from SEC filings.2016: $597.46M2017: $526.18M2018: $716.40M2019: $353.00M2020: $628.39M2021: $768.97M2022: $784.71M2023: $820.57M2024: $1.02B2025: $1.11B$1.11B2016Gross Profit (USD)2025Fiscal YearGross ProfitChange YoY2025$1.11B+9.1%2024$1.02B+24.4%2023$820.57M+4.6%2022$784.71M+2.0%2021$768.97M+22.4%2020$628.39M+78.0%2019$353.00M-50.7%2018$716.40M+36.2%2017$526.18M-11.9%2016$597.46M—Other metrics: RevenueCost of RevenueOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share